VCA Animal Hospitals and Zoetis Partner on a Successful Clinical Study on New-to-Market Clavamox® Chewable Antibiotic Tablets
August 14 2017 - 11:30AM
Business Wire
New chewable tablets make it much easier to
administer needed veterinary medication
VCA Animal Hospitals, the nation’s largest animal hospital
chain, continues to support clinical research with their Clinical
Studies program. In a recent collaboration, VCA partnered with
Zoetis, the world’s leading animal health company, to conduct a
clinical study that tested the palatability of Clavamox® Chewable
tablets with client-owned dogs at VCA veterinary hospitals across
the U.S. The study was conducted across VCA’s national network of
hospitals in accordance with a protocol approved by FDA’s Center
for Veterinary Medicine for a chewable version of an incredibly
important, and previously approved, veterinary antibiotic. A total
of 1,567 doses were administered to 112 dogs, resulting in an 83
percent overall voluntary acceptance rate for Clavamox Chewable
when offered from an empty bowl or owner’s hand.*1
“Having this important antibiotic available as a chewable form
will mean it is much easier for our clients to administer this
medication,” said Philip Bergman, DVM, PhD, Dipl ACVIM, VCA
Director of Clinical Studies. “This clinical study is another
example of a successful partnership between Zoetis and VCA, as we
are both dedicated to moving veterinary medicine forward by
bringing new medications to our patients and their owners.”
The VCA Clinical Studies program started four years ago and has
coordinated a large number of sponsored studies with various
industry partners. The program also performs non-sponsored studies
with many VCA clinicians, residents and interns for the advancement
of research in clinical animal care and has multiple ongoing
collaborations with veterinary universities in North America and
the UK. For additional information about the VCA Clinical Studies
program, contact Dr. Bergman at philip.bergman@vca.com.
About Zoetis
Zoetis is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on more
than 60 years of experience in animal health, Zoetis discovers,
develops, manufactures and markets veterinary vaccines and
medicines, complemented by diagnostic products, genetic tests,
biodevices and a range of services. Zoetis serves veterinarians,
livestock producers and people who raise and care for farm and
companion animals with sales of its products in more than 100
countries. In 2016, the company generated annual revenue of US$4.9
billion with approximately 9,000 employees. For more information,
visit www.Zoetis.com.
About VCA
VCA (WOOF on NASDAQ) is a leading provider of pet health care
services in the country delivered through over 800 small animal
veterinary hospitals in the US and Canada, a preeminent nationwide
clinical laboratory system that services all 50 states and Canada
(Antech Diagnostics), the leading animal diagnostic imaging company
in the market (Sound), and Camp Bow Wow (CBW), the nation’s Premier
Doggy Day and Overnight Camp® franchise, an Inc. 5000 company.
VCA Animal Hospitals operates more than 800 small animal
veterinary hospitals in the U.S. and Canada. The hospitals are
staffed by more than 4,500 fully qualified, dedicated and
compassionate veterinarians to give pets the very best in medical
care, of which over 500 are board-certified specialists who are
experts in areas such as Oncology, Cardiology, Emergency and
Critical Care, and Surgery for animals. VCA Animal Hospitals
provides a full range of general practice services to keep pets
well and specialized treatments when pets are ill. For more
information, please visit www.VCAhospitals.com or follow on Twitter
@vcapethealth.
1 Data on file. CLAVAMOX CHEWABLE Tablets Palatability Study in
Client-Owned Dogs. Study No. A163C-US-13-170, Zoetis Inc.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170814005250/en/
Agnes Huff Communications GroupAgnes Huff, PhD,
310-641-2525ahuff@ahuffgroup.com
Petco Health and Wellness (NASDAQ:WOOF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Petco Health and Wellness (NASDAQ:WOOF)
Historical Stock Chart
From Apr 2023 to Apr 2024